Wilson RL, Taaffe DR, Newton RU, Hart NH, Lyons-Wall P, Galvo DA
A major concern with GLP-1RAs, despite their potent anti-obesity effects, is post-treatment weight rebound [16]
Overall, positive reviews emphasize gradual, sustainable benefits rather than sudden, drastic changes
however, these are investigational trial doses and do not constitute approved prescribing information
Beyond summarizing pharmacological efficacy, we introduce a structured, clinically oriented psychological framework designed to guide clinical decision-making and inform future translational research, linking neurobehavioral science with routine obesity care and emphasizing personalization, early identification of relapse indicators, and the integration of psychological and pharmacological interventions
This tirzepatide summary boils down to one truth: its a powerful tool, not a magic wand